Thiogenesis Therapeutics Corp (TTI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 02-2021 | 12-2020 | 12-2019 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | 19 | 184 |
| Receivables | N/A | 1 | 2 |
| Other current assets | 146 | 0 | 0 |
| TOTAL | $146 | $52 | $292 |
| Non-Current Assets | |||
| TOTAL | $0 | $0 | $0 |
| Total Assets | $146 | $52 | $292 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | N/A | 320 | N/A |
| Accounts payable and accrued liabilities | N/A | 29 | 12 |
| Accrued Expenses | 63 | N/A | N/A |
| TOTAL | $63 | $359 | $12 |
| Non-Current Liabilities | |||
| TOTAL | $0 | $0 | $0 |
| Total Liabilities | $63 | $359 | $12 |
| Shareholders' Equity | |||
| Common Shares | 270 | 1 | 1 |
| Retained earnings | -229 | -927 | -327 |
| Other shareholders' equity | 0 | 619 | 606 |
| TOTAL | $83 | $-307 | $280 |
| Total Liabilities And Equity | $146 | $52 | $292 |